Osaka, Japan

Shun Shibata

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2022-2023

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Shun Shibata

Introduction

Shun Shibata is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of stem cell research, particularly in the differentiation of pluripotent stem cells. His work has implications for cell therapy and regenerative medicine.

Latest Patents

Shun Shibata holds two patents that showcase his innovative approaches. The first patent is a method for controlling the differentiation of pluripotent stem cells. This method involves selecting a laminin or a fragment thereof based on its binding affinity for pluripotent stem cells. The process allows for the production of a cell population containing any desired proportion of differentiated cells, which is beneficial for cell therapy-based treatment strategies for various diseases. The second patent pertains to mesenchymal stem cell-derived exosomes. These microparticles promote the growth of corneal epithelial stem cells and maintain them in an undifferentiated state, thereby protecting the corneal epithelium.

Career Highlights

Shun Shibata has worked with prestigious institutions such as Osaka University and Rohto Pharmaceutical Co., Ltd. His research has been pivotal in advancing the understanding of stem cell biology and its applications in medicine.

Collaborations

Shun Shibata has collaborated with notable colleagues, including Kohji Nishida and Kiyotoshi Sekiguchi. Their joint efforts have contributed to the advancement of research in stem cell therapies.

Conclusion

Shun Shibata's innovative work in stem cell research and his patents reflect his commitment to advancing medical science. His contributions are paving the way for future developments in cell therapy and regenerative medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…